APA

Fernández-Vega B., Fernández-Vega Á., Rangel C. M., Nicieza J., Villota-Deleu E., Vega J. A. & Sanchez-Avila R. M. (20160412). Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy?. : Case reports in ophthalmology.

Chicago

Fernández-Vega Beatriz, Fernández-Vega Álvaro, Rangel Carlos Mario, Nicieza Javier, Villota-Deleu Eva, Vega José A and Sanchez-Avila Ronald M. 20160412. Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy?. : Case reports in ophthalmology.

Harvard

Fernández-Vega B., Fernández-Vega Á., Rangel C. M., Nicieza J., Villota-Deleu E., Vega J. A. and Sanchez-Avila R. M. (20160412). Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy?. : Case reports in ophthalmology.

MLA

Fernández-Vega Beatriz, Fernández-Vega Álvaro, Rangel Carlos Mario, Nicieza Javier, Villota-Deleu Eva, Vega José A and Sanchez-Avila Ronald M. Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy?. : Case reports in ophthalmology. 20160412.